Conclusion:
The alterations in the hemostatic balance in COVID-19 patients are strongly disturbed and contribute to a high prothrombotic status. The high rate of venous thromboembolism in COVID-19 patients goes along with derangements in coagulation laboratory parameters.
Hemostasis testing has an important role in diagnosed COVID-19 patients. Elevated D-dimer levels were found to be a crucial laboratory marker in the risk assessment of thrombosis in COVID-19 patients.
References:
1.     Harfouch RM, Moualla YM, Shahoud SM, Belal LA, Mohammad BS, Mustafa NM, Souliman OA, Elshemali YI (2021). Epidemiology of COVID- 19 in the most pandemic Countries: A review article. Acad . J. Biotechnol. 9(1): 021-027
2.     Rim M. Harfouch, Samer Alshaikh, Mohammad Alshimaly, Amany Assaad, Jehan Ahmad, Haya Zoughaibi, Maher Hammadi, Yahya Elshimali. Therapeutic approaches for COVID 19: Challenges and successes. Ann Clin Anal Med 2021;12(2):228-233
3.     Savla SR, Prabhavalkar KS, Bhatt LK. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Rev Anti Infect Ther. 2021;19(11):1397-1413. doi:10.1080/14787210.2021.1915129
4.     Poudel A, Poudel Y, Adhikari A, Aryal BB, Dangol D, Bajracharya T, Maharjan A, Gautam R. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS One. 2021 Aug 26;16(8):e0256744. doi: 10.1371/journal.pone.0256744. PMID: 34437642; PMCID: PMC8389366.
5.     Zhao R, Su Z, Komissarov AA, et al. Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression. Front Immunol. 2021;12:691249. Published 2021 May 7. doi:10.3389/fimmu.2021.691249
6.     Savla SR, Prabhavalkar KS, Bhatt LK. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Rev Anti Infect Ther. 2021;19(11):1397-1413. doi:10.1080/14787210.2021.1915129
7.     Harfouch RM. Cytokine Storm Syndrome in COVID-19 Patients: Characteristics and Diagnosis. Ann Clin Med Case Rep. 2021;7(18):1-3.
8.     Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management [published correction appears in Thromb Res. 2020 Nov 26;:]. Thromb Res. 2020;194:101-115. doi:10.1016/j.thromres.2020.06.029
9.     Zhao R, Su Z, Komissarov AA, et al. Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression. Front Immunol. 2021;12:691249. Published 2021 May 7. doi:10.3389/fimmu.2021.691249.
10.  Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-2040. doi:10.1182/blood.2020006000.